GGrantIndex
← Search

RALOXIFENE HYDROCHLORIDE, PLACEBO AND PREMARIN IN PREVENTION OF OSTEOPOROSIS

$0M01FY2000RRNIH

Beth Israel Deaconess Medical Center, Boston MA

Investigators

Linked publications & trials

Abstract

This multicenter prospective study is designed to establish the effect of long-term therapy with raloxifene hydrochloride on lumbar spine and hip bone mineral density in healthy, postmenopausal, hysterectomized women versus placebo versus Premarin on biochemical markers of bone metabolism in the same patients; and to establish the safety of chronic administration of the drug.

View original record on NIH RePORTER →